VA Dramatically Reduces ESA Use for Cancer-Related Anemia

COLUMBIA, SC — Erythropoiesis-stimulating agents were indicated for use in patients with cancer who receive noncurative myelosuppressive chemotherapy, with the intention of mitigating symptoms and side effects to decrease the need for red blood cell...

A Battle on Two Fronts: Coronavirus and Addiction

BETHESDA, MD—Researchers at the National Institute on Drug Abuse (NIDA) had been fighting one daunting national health crisis already when the COVID-19 pandemic launched its attack on the U.S. Now, these federal scientists face the dual challenges of reducing the...